坎伯蘭藥業 CPIX 深 滬
已收盤 04-02 16:00:00 美东时间
3.17
+0.070
+2.26%
華盛通- 最 高3.225
- 今 開3.09
- 成交量 8.10万股
- 最 低 3.00
- 昨 收 3.10
- 總市值 4741.25万
- 52周最高 6.265
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 1.85
- 委 比 -2.56%
- 總股本 1495.66万
- 歷史最高 8.02
- 量 比 1.73
- 振 幅 7.26%
- 歷史最低 1.04
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Cumberland Pharmaceuticals 第四季度调整后每股收益（EPS）为 -0.01 美元
Cumberland Pharmaceuticals Q4 Adjusted EPS USD -0.01
03-04 06:07
Cumberland Q4 Adj. EPS $(0.01) Up From $(0.02) YoY, Sales $13.679M Up From $10.436M YoY
Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $13.679 million in sales this
03-04 06:02
快讯 | Cumberland Pharmaceuticals 报告称2025年第四季度收入增长31%。
Cumberland Pharmaceuticals Reports 31% Fourth Quarter 2025 Revenue Growth
03-04 06:00
Earnings Scheduled For March 3, 2026
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA®
NASHVILLE, Tenn., Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, today...
02-25 20:00
Joint U.S. Commercialization of RedHill's Talicia® Commences
The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has s...
02-25 20:00
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
NASHVILLE, Tenn., Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its 2025 financial re...
02-25 05:05
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban
Cumberland Pharmaceuticals ( ($CPIX) ) has issued an announcement. On February ...
02-05 06:51
FDA Grants Fast Track Designation For Cumberland Pharma's Oral Therapy Targeting Fatal Form Of Heart Disease In Duchenne Muscular Dystrophy Patients
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted
02-04 22:06
Cumberland's Caldolor Injection Receives Permanent J-Code With Reimbursement
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), today announced an important update regarding its Caldolor® (ibuprofen) Injection. The product's permanent J-code, J1741, is now officially associated with a
2025-12-08 22:11
